A research team led by Dr. Geneviève Bernard at the Research Institute of the McGill University Health Center (RI-MUHC) has reached an important milestone in research into leukodystrophies, which are deadly neurodegenerative diseases that affect approximately one in 4,700 children and remain incurable to this day.
The team has succeeded in creating the first representative animal model of 4H leukodystrophy, one of the common forms of the disease. This is a crucial step in the development of treatments, and was recently described in an article published in the journal"This significant progress will allow us to understand the disease better and to test putative therapies, which we have already started doing.
"It was essential to create a representative model of the disease to develop therapeutic approaches in the laboratory in future preclinical studies," explains Dr. Bernard, who is also associate professor in the Department of Neurology and Neurosurgery, and Pediatrics, at McGill University."The lab is now working on the development of the first gene replacement therapy approach for the disease.
"This discovery is a critical building block in the quest to discover effective treatments for people affected by 4H and demonstrates the advances that are possible when patients, families, and researchers come together to identify the most important problems to solve and find the right people to solve them.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Study: Reductions in sexual mixing ended mpox outbreak in England, vaccination prevented resurgences in 2023The rapid outbreak of mpox (formerly known as monkeypox) in 2022 likely resulted from high levels of sexual mixing among some gay, bisexual and other men who have sex with men (GBMSM), with the initial downturn in cases probably due to a reduction in sexual contacts among these men, according to new research led by the National Institute for Health and Care Research (NIHR) Health Protection Research Unit (HPRU) in Behavioral Science and Evaluation. The HPRU is a partnership between the University of Bristol and the UK Health Security Agency (UKHSA).
Consulte Mais informação »
BP boss Bernard Looney quits over conduct allegationsBP said that Bernard Looney had not been 'fully transparent' in disclosing past relationships with colleagues
Consulte Mais informação »
Chief executive Bernard Looney resigns – BP statement in fullThe board received allegations about his conduct in May 2022.
Consulte Mais informação »
Chief executive Bernard Looney resigns – BP statement in fullThe board received allegations about his conduct in May 2022.
Consulte Mais informação »
BP chief executive Bernard Looney quits £10m-a-year job over 'past relationships with colleagues'The 53-year-old had served in the role for less than four years. He admitted not being 'fully transparent' about personal liaisons with staff, the energy giant said in a statement.
Consulte Mais informação »
Bernard Looney spent entire working life with BP before shock resignationBernard Looney, who has spent his entire career at BP after joining as an engineer in 1991, resigned as chief executive with immediate effect.
Consulte Mais informação »